Harmonizing science and business agendas for growth in new biotechnology firms: Case comparisons from five countries

Technovation

Volumn 27, Issue 11, 2007, Pages 676-692

  Ireland, David C ^a,b   Hine, Damian ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Commercialization; Competing agendas; New biotechnology firm

Indexed keywords

BIOTECHNOLOGY; COMPETITION; SUSTAINABLE DEVELOPMENT;

COMMERCIALIZATION; COMPETING AGENDAS; NEW BIOTECHNOLOGY FIRMS (NBF);

INDUSTRIAL MANAGEMENT;

EID: 35248870135     PISSN: 01664972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.technovation.2007.05.016     Document Type: Article

References (87)

1. Acs Z. "Schumpeterian Capitalism" in Capitalist Development: Toward a Synthesis of Capitalist Development and the "Economy as a Whole" (2006), Edward Elgar, Cheltenham, UK
2. Aldrich H. Organizations Evolving (1999), Sage Publications, Thousand Oaks, CA
3. Aldrich H.E. Organisations and Environments (1979), Prentice-Hall, Englewood Cliffs, NJ
4. Aldrich H.E. Organizations Evolving (2006), Sage, Thousand Oaks, CA
5. Altman A. Plant biotechnology in the 21st century: the challenges ahead. Electronic Journal of Biotechnology 2 (1999) 1-5
6. Ardichvili A., Cardozo R., and Ray S. A theory of entrepreneurial opportunity identification and development. Journal of Business Venturing 18 (2003) 105-123
7. Austin J. Salary survey: US life scientists report rising salaries and high job satisfaction. Science 341 (2006) 842-847
8. Barney J.B. Organizational culture: can it be a source of sustained competitive advantage?. Academy of Management Review 11 (1986) 656-665
9. Baron J.N., Hannan M.T., and Burton M.D. Building the iron cage: determinants of managerial intensity in the early years of organizations. American Sociological Review 64 (1999) 527-547
10. Batchelder K., and Miller P. A change in the market-investing in diagnostics. Nature Biotechnology 24 (2006) 922-926
11. Baum J., and Haveman H. Love thy neighbour? Differentiation and agglomeration in the Manhattan hotel industry, 1898-1990. Administrative Science Quarterly 42 (1997) 304-338
12. Baum J., and Silverman B. Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups. Journal of Business Venturing 19 (2004) 411-436
13. Bernstein, K., 2003. The Bernstein Report on BioBusiness. BioCentury.
14. Bhave M.P. A process model of entrepreneurial venture creation. Journal of Business Venturing 9 (1994) 223-242
15. Bontis N. Managing organizational knowledge by diagnosing intellectual capital: framing and advancing the state of the field. International Journal of Technology Management 18 (1999) 433-462
16. Bontis N., and Girardi J. Teaching knowledge management and intellectual capital lessons: an empirical examination of the Tango simulation. International Journal of Technology Management 20 (2000) 545-554
17. Bontis N., Dragonetti N., Jacobsen K., and Roos G. The knowledge toolbox: a review of the tools available to measure and manage intangible resources. European Management Journal 17 (1999) 391-402
18. Bozeman B., and Corley E. Scientists' collaboration strategies: implications for scientific and technical human capital. Research Policy 33 (2004) 599-616
19. Bozeman B., and Rogers J. A churn model of scientific knowledge value: internet researchers as a knowledge value collective. Research Policy 31 (2002) 769-794
20. Bozeman B., Dietz J., and Gaughan M. Scientific and technical human capital: an alternative model for research evaluation. International Journal of Technology Management 22 (2001) 616-630
21. Brown F. Uniting Science and Business: The Challenges for Biotech Start-ups (2004), Northbank Communications, UK
22. Camarinha-Matos L.M., and Afsarmanesh H. Results assessment and impact creation in collaborative research-an example from the ECOLEAD project. Technovation 27 (2007) 65-77
23. Cassell C., and Symon G. Qualitative Methods in Organisational Research: A Practical Guide (1994), Sage, London
24. Champion, D., 2001. Mastering the value chain. Harvard Business Review, June, pp. 109-115.
25. Cohen W., and Levinthal D.A. Absorptive capacity: a new perspective on learning and innovation. Administrative Science Quarterly 35 (1990) 128-152
26. Commission of the European Communities, 2002. Communication from the Commission to the Council, the European Parliament, the Economic and Social Committee and the Committee of the Regions. Life Sciences and Biotechnology-A Strategy for Europe.
27. Connell J. The Role of Universities and Market Factors in the Location of Biotechnology Industrial Clusters (2002), University of California, Los Angeles
28. Conway B.J. Biotech and Pharma in a Turbulent World (2005), Genetic Engineering News
29. Cooke P., Kaufmann D., Levin C., and Wilson R. The bioscience knowledge value chain and comparative incubation models. Journal of Technology Transfer 31 (2006) 115-129
30. Cordis, 2004. Mentalities must change if we want to remain competitive, informal Competitiveness Council concludes. CORDIS FOCUS, 12 July 04.
31. Cortada J.W., and Fraser H.E. Mapping the future in science-intensive industries: lessons from the pharmaceutical industry. IBM Systems Journal 44 (2005) 163-183
32. Covin T.J., and Stivers B.P. Knowledge management focus in US and Canadian firms. Creativity and Innovation Management 6 (1997) 140-150
33. Dyer, G., 2003. Biotech companies running out of money. Financial Times, Nov 17, p. 1.
34. Eisenhardt K.M. Building theories from case study research. Academy of Management Review 14 (1989) 532-550
35. Eisenhardt K.M. Better stories and better constructs: the case for rigor and comparative logic. The Academy of Management Review 16 (1991) 620-627
36. Ernst & Young, 2006. The global biotechnology report. The Global Biotechnology Report.
37. Esposito R.S., and Ostro M.J. Strategic consolidation: the biotechnology business model for the 21st century. Nature Biotechnology 17 (1999) BE16-BE17
38. Fisken J., and Rutherford J. Business models and investment trends in the biotechnology industry in Europe. Journal of Commercial Biotechnology 8 (2002) 191-199
39. Garnsey E., and Hefferman P. Growth setbacks in new firms. Futures 37 (2005) 675-697
40. Gellert E. Systematic observation: a method in child study. Harvard Educational Review 225 (1955) 179-195
41. Golob E.R. Generating Spin-Offs from University-based Research: An Institutional and Entrepreneurial Analysis (2003), Rutgers The State University of New Jersey, New Brunswick, NJ
42. Goodman E.A., Zammuto R.F., and Gifford B.D. The competing values framework: understanding the impact of organisational culture on the quality of work life. Organisation Development Journal 19 (2001) 58-68
43. Greetham E.M. How do you measure "success" in a biotechnology company?. Nature Biotechnology 16 (1998) 59-60
44. Greiner L.E. Evolution and revolution as organizations grow. Harvard Business Review 50 (1972) 37-46
45. Hannan M.T., and Freeman J.H. Organizational Ecology (1989), Harvard University Press, Cambridge
46. Henderson R.M., and Clark K.B. Architectural innovation: the reconfiguration of existing product technologies and the failure of established firms. Administrative Science Quarterly 35 (1990) 9-30
47. Hine D. Innovative Methodologies in Enterprise Research (2007), Edward Elgar, Cheltenham, UK
48. Hine D., and Kapeleris J. Innovation and Entrepreneurship in Biotechnology: An International Perspective (2006), Edward Elgar, Cheltenham, UK
49. Huang S. The nonobviousness requirement for biotechnology inventions-resolving uncertainty in favor of innovation. Managerial and Decision Economics 26 (2005) 139-149
50. Hugo O., and Garnsey E. Problem-solving and competence creation in the early development of new firms. Managerial and Decision Economics 26 (2005) 139-149
51. IFPMA, 2006. International Federation of Pharmaceutical Manufactures and Associations Reports. 〈http://www.ifpma.org/Issues/issues_research.aspx〉.
52. Janesick V.J. The Dance of Qualitative Research Design: Metaphor, Methodolatry, and Meaning (1998), Sage Publications, London
53. Johne A., and Davies R. Approaches to stimulating change in mature insurance companies. British Journal of Management 10 (1999) 19-30
54. Kazanjian R.K. Relation of dominant problems to stages of growth in technology-based new ventures. Academy of Management Journal 31 (1988) 257-279
55. Kelley D.J., and Nakosteen R.A. Technology resources, alliances, and sustained growth in new, technology-based firms. IEEE Transactions on Engineering Management 52 (2005) 292
56. Khilji S.E., Mroczkowski T., and Bernstein B. From invention to innovation: toward developing an integrated innovation model for biotech firms. The Journal of Product Innovation Management 23 (2006) 528-540
57. Krause C. Organizational models evolve to meet advancing drug discovery technology. Chemical Market Reporter 263 (2003) 12
58. Loffler A. Trends in biotechnology: implications for the pharmaceutical industry. International Journal of Medical Marketing 2 (2002) 345-348
59. Lyles M.A., Saxton T., and Watson K. Venture survival in a transition economy. Journal of Management 30 (2004) 351-375
60. Mascitelli R. A framework for sustainable advantage in global high-tech markets. International Journal of Technology Management 17 (1999) 240-259
61. Mcgahan A.M. How industries evolve. Business Strategy Review 11 (2000) 1-16
62. Mcelroy D. Valuing the product development cycle in agricultural biotechnology-what's in a name?. Nature Biotechnology 22 (2004) 817-822
63. Mckelvey M., Rickne A., and Laage-Hellman J. The Economic Dynamics of Modern Biotechnology (2004), Edward Elgar, Cheltenham, UK
64. Mcmullen J.S., and Shepherd D.A. Entrepreneurial action and the role of uncertainty in the theory of the entrepreneur. Academy of Management Review 31 (2006) 132-152
65. Murray F. The role of academic inventors in entrepreneurial firms: sharing the laboratory life. Research Policy 33 (2004) 643-659
66. Niosi J., and Banik M. The evolution and performance of biotechnology regional systems of innovation. Cambridge Journal of Economics 29 (2005) 343-357
67. Nonaka I., and Takeuchi H. The Knowledge-Creating Company (1995), Oxford University Press, New York
68. Nonaka I., and Takeuchi H. A theory of organizational knowledge creation. International Journal of Technology Management 11 (1996) 833-845
69. OECD, 2006. Biotechnology Statistics 2006. Organisations for Economic Co-operation and Development Online Reports. 〈http://www.oecd.org/dataoecd/51/59/36760212.pdf〉.
70. Patton M.Q. Qualitative Evaluation and Research Methods (1990), Sage, Newbury Park
71. Perry, C., Coote, L., 1994. Process of a case study research methodology: tool for management development? National Conference of the Australian-New Zealand Association of Management, Wellington, pp. 1-22.
72. Purcell D.J. Financing biotechnology in an inefficient market. Nature Biotechnology 17 (1999) BE31-BE32
73. Queensland Government, 2001. Code of Ethical Practice for Biotechnology in Queensland. Department of Innovation and Information Economy, 5, Queensland Government.
74. Quinn R.E., and Cameron K. Organizational life cycles and shifting criteria of effectiveness: some preliminary evidence. Management Science 29 (1983) 33-51
75. Quinn R.E., and Rohrbaugh J. A spatial model of effectiveness criteria: toward a competing values approach to organisational analysis. Management Science 29 (1983) 363-377
76. Reichert J.M. Trends in development and approval times for new therapeutics in the US. Nature Reviews Drug Discovery 2 (2003) 695-702
77. Rowley J. Using case studies in research. Management Research News 25 (2002) 16-27
78. Scarlett J.A. Biotechnology's emerging opportunities: lessons from the Bauhaus. Nature Biotechnology 17 (1999) E13-E15
79. Schachman H.K. From "Publish or Perish" to "Patent and Prosper". Journal of Biological Chemistry 281 (2006) 6889-6903
80. Schumpeter J. Business Cycles: A Theoretical, Historical, and Statistical Analysis of the Capitalist Process (1934), McGraw-Hill, New York
81. Schumpeter J. The Theory of Economic Development (1934), Harvard University Press, Cambridge, MA
82. Stake R.E. The Art of Case Study Research (1995), Sage Publications, Thousand Oaks, CA
83. Stewart T.A. Intellectual Capital: The New Wealth of Organizations (1997), Doubleday, New York
84. Stuart T.E., and Ding W.W. When do scientists become entrepreneurs? The social structural antecedents of commercial activity in the academic life sciences. The American Journal of Sociology 112 (2006) 97-144
85. Tahvaninen A.J., and Hermans R. Funding intellectual capital abundant technology development: empirical evidence from the Finnish biotechnology business. Knowledge Management Research & Practice 3 (2005)
86. Yaroshevsky-Glanville M. Careers and recruitment: strategic HR for today's biotechnology companies. Nature Biotechnology 22 (2004) 1189
87. Yin R.K. Case Study Research: Design and Method (1994), Sage, Thousand Oaks, CA